KBioBox llc, founded in 2013 and headquartered in the United States, operates in the Analytics, Biopharma, Biotechnology, and Pharmaceutical sectors. The company's slogan, "Bioinformatics engine for Next Generation Sequencing with superior search speeds and customizable gene edit off-target analysis," captures its unique value proposition in the field of bioinformatics.
KBioBox specializes in rapid precision off-target analysis and gene edit biodesign, addressing the increasing demand for real-time genetic data assessment. Their flagship product, the BioEngine, is notable for its ability to conduct comprehensive genomic searches within minutes. This capability is particularly relevant for clients in need of complex genetic sequence analyses.
The company last received a $100.00K Seed investment on 01 June 2015. Despite the absence of recent funding, KBioBox's technological expertise and market positioning suggest potential for attracting future investment to fuel growth and expand their service offerings.